Google’s parent company, Alphabet, is launching an operation dedicated to drug discovery.
The new company, called Isomorphic Labs, will build on recent research from DeepMind, a London-based artificial intelligence lab also owned and operated by Alphabet.
Demis Hassabis, the co-founder and chief executive of DeepMind, will also serve as chief executive of Isomorphic Labs as it maps out its technical strategy and hires its first employees.
Isomorphic and DeepMind announced the creation of the…
Source link